Boulder Hill Capital Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-9,100
Closed -$669K 247
2021
Q4
$669K Buy
+9,100
New +$748K 0.65% 30

Other funds holding ASTH

Boulder Hill Capital Management's ASTH Position: Q1 2022 in Review

Boulder Hill Capital Management sold out of Astrana Health (ASTH) in Q1 2022, closing a stake of 9,100 shares — an estimated $669K sold.

Boulder Hill Capital Management first reported a position in ASTH in Q4 2021 and held it in 1 quarter. The position peaked at $669K in Q4 2021. 139 funds tracked by Wall St. Rank hold ASTH as of Q1 2022.

  • Boulder Hill Capital Management reported no remaining Astrana Health position as of Q1 2022 after selling out during the quarter.
  • Boulder Hill Capital Management sold 9,100 Astrana Health shares in Q1 2022, an estimated $669K.
  • Boulder Hill Capital Management first reported a position in Astrana Health in Q4 2021 and held it in 1 quarter.
  • Boulder Hill Capital Management's Astrana Health position peaked at $669K in Q4 2021.
  • 139 funds tracked by Wall St. Rank held Astrana Health as of Q1 2022.

Based on Boulder Hill Capital Management's 13F filing for Q1 2022, filed 12 May 2022.